ACPE UAN #: 0233-0000-19-083-H01-P
Release Date: November 1, 2019
Expiration Date: November 1, 2022
Activity Type: Knowledge-based
Contact Hours: 1.5
Activity Fee: Member: FREE Non-Member: $30
Target Audience: Pharmacists who practice in managed care settings.
The current understanding of Alzheimer’s disease is evolving. In 2011, clinical diagnostic criteria for Alzheimer’s disease dementia were revised, and research guidelines for earlier stages of the disease were characterized to reflect a deeper understanding of the disorder. The development of these guidelines was led by the National Institutes of Health and the Alzheimer’s Association. In 2018, the guidelines were updated further to describe three stages of Alzheimer’s disease: preclinical, mild cognitive impairment (MCI) and Alzheimer’s dementia. New treatments are projected to change how Alzheimer’s disease is recognized, diagnosed, managed, treated and reimbursed. How will this affect current clinical practice? How will the beneficiaries access these medications? Value-based payment arrangements may provide a solution for patients to use new drugs, but these arrangements are not without operational, clinical and legal challenges. Value-based payment arrangements are ideal for early-stage Alzheimer’s Disease management due to its likely long-term impact, high diagnostic costs, and broad impact on nontraditional payer entities. This session will provide content on the current research and development of Alzheimer’s Disease and provide case studies on value-based payment arrangements that can be considered for early-stage Alzheimer’s Disease treatments or prevention.
At the completion of this activity, participants should be able to:
- Describe how the recognition, diagnosis, management, and treatment of Alzheimer’s Disease is evolving.
- Identify at least one emerging preventive treatment for Alzheimer’s Disease.
- Explain how value-based payment arrangements can be used across different lines of business for various treatments.
- Discuss considerations when using different types of value-based payment arrangements for early-stage treatments or preventive therapies for Alzheimer’s Disease.
Schedule of Educational Activity
This activity consists of an audio recording, pre-test assessment questions (not required to pass to continue), post-test questions (required to pass with a score of 70% or higher) and a specific activity evaluation.
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
As an accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of continuing pharmacy education (CPE) activities. AMCP intends that all CPE activities be independent, objective, balanced, evidence-based, and free of any commercial bias.
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP Nexus 2019.
CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Isha Bangia | PharmD, MBA | Manager, US Market Access | Certara USA, Inc. | New York, New York.
System Technical Requirements/Viewing Requirements: System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE UAN #0233-0000-19-083-H01-P||1.5 Contact Hours||November 01, 2019 - November 01, 2022|